Categories AlphaGraphs, Earnings, Health Care
Bristol Myers Squibb (BMY) Q2 2022 Earnings: Key financials and quarterly highlights
Adjusts 2022 GAAP EPS Guidance; Reaffirms Non-GAAP EPS Guidance
Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today.
Total revenue grew 2% year-over-year to $11.9 billion.
Net earnings attributable to BMY shareholders stood at $1.4 billion, or $0.66 per share vs. $1.1 billion, or $0.47 per share for the same period a year ago.
Most Popular
Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode
Over the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant player in the medical industry, benefitting from its unique business model and growth strategy focused on constant innovation.
Key takeaways from PepsiCo’s Q3 2024 earnings report
Shares of PepsiCo, Inc. (NASDAQ: PEP) gained over 1% on Tuesday even though the company delivered mixed results for the third quarter of 2024 and lowered its guidance for the
PEP Earnings: All you need to know about PepsiCo’s Q3 2024 earnings results
PepsiCo, Inc. (NASDAQ: PEP) reported its third quarter 2024 earnings results today. Net revenue dipped 0.6% to $23.3 billion compared to the same period a year ago. Organic revenue growth
